Leng, H., & Simon, K. (2019). Translational potential of a novel osteoclast inhibitor, eliglustat, in myeloma bone disease.
Citace podle Chicago (17th ed.)Leng, H., a K. Simon. Translational Potential of a Novel Osteoclast Inhibitor, Eliglustat, in Myeloma Bone Disease. 2019.
Citace podle MLA (9th ed.)Leng, H., a K. Simon. Translational Potential of a Novel Osteoclast Inhibitor, Eliglustat, in Myeloma Bone Disease. 2019.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..